NO20021920L - Behandling eller forebyggelse av hypotensjon og sjokk - Google Patents

Behandling eller forebyggelse av hypotensjon og sjokk

Info

Publication number
NO20021920L
NO20021920L NO20021920A NO20021920A NO20021920L NO 20021920 L NO20021920 L NO 20021920L NO 20021920 A NO20021920 A NO 20021920A NO 20021920 A NO20021920 A NO 20021920A NO 20021920 L NO20021920 L NO 20021920L
Authority
NO
Norway
Prior art keywords
treatment
hypotension
prevention
shock
mammal
Prior art date
Application number
NO20021920A
Other languages
English (en)
Other versions
NO329889B1 (no
NO20021920D0 (no
Inventor
Riitta Heino
Tiina Leino
Tarja Lehtimaeki
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of NO20021920D0 publication Critical patent/NO20021920D0/no
Publication of NO20021920L publication Critical patent/NO20021920L/no
Publication of NO329889B1 publication Critical patent/NO329889B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20021920A 1999-10-29 2002-04-23 Anvendelse av et imidazolderivat til fremstilling av et legemiddel til a forhindre eller behandle hypotensjon og sjokk som skyldes lav perifer motstand, eller kardiopulmonaer gjenopplivning NO329889B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16212099P 1999-10-29 1999-10-29
PCT/FI2000/000935 WO2001030347A1 (en) 1999-10-29 2000-10-27 Treatment or prevention of hypotension and shock

Publications (3)

Publication Number Publication Date
NO20021920D0 NO20021920D0 (no) 2002-04-23
NO20021920L true NO20021920L (no) 2002-06-14
NO329889B1 NO329889B1 (no) 2011-01-17

Family

ID=22584242

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021920A NO329889B1 (no) 1999-10-29 2002-04-23 Anvendelse av et imidazolderivat til fremstilling av et legemiddel til a forhindre eller behandle hypotensjon og sjokk som skyldes lav perifer motstand, eller kardiopulmonaer gjenopplivning

Country Status (11)

Country Link
US (4) US20070185181A1 (no)
EP (1) EP1223931B1 (no)
JP (1) JP4741131B2 (no)
AT (1) ATE312606T1 (no)
AU (1) AU778522B2 (no)
CA (1) CA2388979C (no)
DE (1) DE60024855T2 (no)
NO (1) NO329889B1 (no)
NZ (1) NZ518447A (no)
RU (1) RU2259827C2 (no)
WO (1) WO2001030347A1 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20022159A0 (fi) * 2002-12-05 2002-12-05 Orion Corp Uusia farmaseuttisia yhdisteitä

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2542738A1 (fr) * 1983-03-18 1984-09-21 Synthelabo Indanyl-2 d2-imidazoline, procede pour la preparer, et compositions pharmaceutiques qui la contiennent
GB2206880B (en) 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
US5124157A (en) 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
FI894911A0 (fi) 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
FR2656610B1 (fr) * 1989-12-29 1992-05-07 Sanofi Sa Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.
ATE376850T1 (de) * 1990-12-05 2007-11-15 Gen Hospital Corp Vorrichtung zum behandeln einen lungengefässverengung und von asthma
US5571840A (en) * 1993-06-22 1996-11-05 The Regents Of The University Of Michigan Method for treating central nervous system ischemia
GB2281206A (en) 1993-08-25 1995-03-01 Orion Yhtymae Oy Use of dexmedetomidine
CN1077886C (zh) * 1993-10-21 2002-01-16 G·D·瑟尔公司 用作一氧化一氮合酶抑制剂的脒基衍生物
US5713907A (en) * 1995-07-20 1998-02-03 Endotex Interventional Systems, Inc. Apparatus and method for dilating a lumen and for inserting an intraluminal graft
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20050281752A1 (en) 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
AR015744A1 (es) 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
US6716867B1 (en) 1998-04-01 2004-04-06 Orion Corporation Use of dexmedetomidine for ICU sedation
US7001609B1 (en) 1998-10-02 2006-02-21 Regents Of The University Of Minnesota Mucosal originated drug delivery systems and animal applications
US6582457B2 (en) 2001-02-15 2003-06-24 Radiant Medical, Inc. Method of controlling body temperature while reducing shivering
US20030022926A1 (en) 2001-05-07 2003-01-30 Lavand'homme Patricia Method for treating neuropathic pain and pharmaceutical preparation therefor
FR2834212B1 (fr) 2001-12-27 2004-07-09 Besins Int Belgique Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
IL147921A0 (en) 2002-01-31 2002-08-14 Abdulrazik Mohammad A method for treating central nervous system disorders by ocular dosing
WO2008003093A2 (en) 2006-06-29 2008-01-03 Questcor Pharmaceuticals, Inc. Pharmaceutical compositions and related methods of treatment

Also Published As

Publication number Publication date
EP1223931B1 (en) 2005-12-14
US8470862B2 (en) 2013-06-25
US9446025B2 (en) 2016-09-20
JP4741131B2 (ja) 2011-08-03
AU1149201A (en) 2001-05-08
US20110294862A1 (en) 2011-12-01
US9078883B2 (en) 2015-07-14
US20070185181A1 (en) 2007-08-09
US20160030392A1 (en) 2016-02-04
CA2388979C (en) 2010-09-14
NO329889B1 (no) 2011-01-17
NO20021920D0 (no) 2002-04-23
US20140100257A1 (en) 2014-04-10
NZ518447A (en) 2004-10-29
JP2003527333A (ja) 2003-09-16
ATE312606T1 (de) 2005-12-15
DE60024855D1 (de) 2006-01-19
EP1223931A1 (en) 2002-07-24
WO2001030347A1 (en) 2001-05-03
CA2388979A1 (en) 2001-05-03
AU778522B2 (en) 2004-12-09
RU2259827C2 (ru) 2005-09-10
DE60024855T2 (de) 2006-08-31

Similar Documents

Publication Publication Date Title
CY1109242T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου
TR199801315T2 (xx) X sendromunun tedavisi i�in bir ppar-alpha ve ppar-gamma antagonistinin kullan�lmas�.
DK0950057T3 (da) 3-pyridylenantiomerer og deres anvendelse som analgetika
NO20006604L (no) Fremgangsmåter og transdermale sammensetninger for lindring av smerte
DE60031714D1 (de) Thrombopoietin-mimetika
EE200200565A (et) Vaskulaarse kahjustava toimega kombinatsioonravi
DK1294379T3 (da) En hidtil ukendt anvendelse af deferipron
SG156681A1 (en) Use of ranolazine in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
NO20021920D0 (no) Behandling eller forebyggelse av hypotensjon og sjokk
EE200100066A (et) Naatriumkloriidi kasutamine kamptotetsiini derivaatide manustamisest tingitud gastrointestinaalsetekõrvaltoimete vähendamiseks
SE9902597D0 (sv) New use
DE60217315D1 (de) Pharmazeutische zusammensetzungen von rapamycines
AU4937499A (en) Use of succinic acid or salts thereof and method of treating insulin resistance
NO20041057L (no) Profylaktisk og terapeutisk anvendelse av hydroksysteroider
ATE238286T1 (de) Neue triazole als therapeutische mittel gegen pilzinfektionen
PL352119A1 (en) Derivatives of aminotetraline for treatment of cardiovascular diseases
RU2002113918A (ru) Лечение или предупреждение гипотензии и шока
RU2002122711A (ru) Способ профилактики вредного воздействия окружающей среды
TR200102262T2 (tr) Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem.
MX9605153A (es) Agentes farmaceuticos para el tratamiento de enfermedades inflamatorias cronicas y agudas.
RU98111356A (ru) Способ лечения ожогового шока
WO2002076405A3 (en) Compositions and methods of treatment of ulcerating diseases, burns, and related conditions

Legal Events

Date Code Title Description
MK1K Patent expired